References
Takada K, Toyokawa G, Okamoto T, et al. Metabolic characteristics of programmed cell death-ligand 1-expressing lung cancer on 18 F-fluorodeoxyglucose positron emission tomography/computed tomography. Cancer Med. 2017;6(11):2552–61.
Liu J, Dong M, Sun X, et al. Prognostic value of 18F-FDG PET7CT in surgical non-small cell lung cancer: a meta-analysis. PLoS One. 11(1):e0146195.
Toyokawa G, Takada K, Okamoto T, et al. Elevated metabolic activity on 18F-FDG PET/CT is associated with the expression of EZH2 in non-small cell lung cancer. Anticancer Res. 2017;37:1393–402.
Lopci E, Rossi S. Tumor metabolism and prognostic role of EZH2 in non-small cell lung cancer. Transl Cancer Res. 2017;6:S982–8.
Palsson-McDermott EM, O’Neill LAJ. The Warburg effect then and now: from cancer to inflammatory diseases. BioEssays. 2013;35:965–73.
Lopci E, Toschi L, Grizzi F, et al. Correlation of metabolic information on FD-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery. Eur J Nucl Med Mol Imaging. 2016;43:1954–61.
Horne ZD, Jack R, Gray ZT, et al. Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer. J Surg Res. 2011;171:1–5.
Tumeh PC, Harview CL, Yearley JH, et al. PD-1 blockade induces responses to inhibiting adaptive immune resistence. Nature. 2014;515:568–71.
Lopci E, Grizzi F, Russo C, et al. Early and delayed evaluation of solid tumours with 64Cu-ATSM PET/CT: a pilot study on semiquantitative and computer-aided fractal geometry analysis. Nucl Med Commun. 2017;38:340–6.
Rashidian M, Ingram JR, Dougan M, et al. Predicting the response to CTLA-4 blocjage by longitudinal noninvasive monitoring of CD8 T cells. J Exp Med. 2017;214:2243.
Acknowledgments
The Italian Association for Research on Cancer (AIRC – Associazione Italiana per la Ricerca sul Cancro) is acknowledged for their support of this research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Potential conflicts of interest
A.C. is supported by a fellowship related to the grant Nr. 18,923 provided by AIRC to E.L.
Rights and permissions
About this article
Cite this article
Grizzi, F., Castello, A. & Lopci, E. Is it time to change our vision of tumor metabolism prior to immunotherapy?. Eur J Nucl Med Mol Imaging 45, 1072–1075 (2018). https://doi.org/10.1007/s00259-018-3988-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-018-3988-1